Hanboonkunupakarn B., van der Pluijm RW., Hoglund R., Pukrittayakamee S., Winterberg M., Mukaka M., Waithira N., Chotivanich K., Singhasivanon P., White NJ., Dondorp AM., Tarning J., Jittamala P.

Artemisinin-based combination therapies (ACTs) have contributed substantially to the global decline in Plasmodium falciparum morbidity and mortality, but resistance to artemisinins and their partner drugs is increasing in Southeast Asia, threatening malaria control. New antimalarial compounds will not be generally available soon.

Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults

Hanboonkunupakarn B., van der Pluijm RW., Hoglund R., Pukrittayakamee S., Winterberg M., Mukaka M., Waithira N., Chotivanich K., Singhasivanon P., White NJ., Dondorp AM., Tarning J., Jittamala P.

DOI

Type

Journal

Publisher

Publication Date

Volume